Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand.

Liver cancer is the most common cancer in males in Thailand and the third in females. A high incidence of cholangiocarcinoma (CCA) is estimated in the northeast of Thailand. Chronic infection with Opisthorchis viverrini (OV) is the major risk factor for development of CCA. It has been demonstrated that HCV infection is a risk factor for CCA in non - endemic area of OV infection. We examined the association of HBV and HCV and risk of CCA in the northeast Thailand. All cases of CCA were recruited between 1999 and 2001 from Nakhon Phanom provincial hospital and all community hospitals in the province. One control per case was selected, matched by sex, age (∓5 years) and residence. 106 case-control pairs were obtained. Anti-OV, HBsAg, and Anti HCV were determined by ELISA. Among 103 age-sex-place of residence matched case-control pairs, there were 7, 0, 0, 96 pairs for anti-HCV (+) case vs. (-) control, (+) case vs. (+) control, (-) case vs. (+) control and (-) case vs. (-) control combinations (OR=7/0). Among 106 matched pairs, there were 9, 2, 4, 91 pairs for the similar four combinations of HBsAg (OR=2.25 (95%CI: 0.63-10.0). If the subject had anti-HCV and/or HBsAg, the OR for CCA was 4.00 (95%CI: 1.29-16.4). Even after adjustment for anti-OV, risk for HBsAg and/or anti-HCV positive was still marginally increased with an OR of 4.69 although not reaching statistical significance (95%CI: 0.98-22.5). Hepatitis B and C virus infection may also play role in the development of CCA in northeast Thailand.

[1]  K. McGlynn,et al.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.

[2]  H. Kinoshita,et al.  Hepatolithiasis associated with cholangiocarcinoma , 1995, World Journal of Surgery.

[3]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[4]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[5]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[6]  Manal M. Hassan,et al.  Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: A Hospital-Based Case–Control Study , 2007, The American Journal of Gastroenterology.

[7]  T. Patel,et al.  Worldwide trends in mortality from biliary tract malignancies , 2002, BMC Cancer.

[8]  K. Ishak,et al.  Thorotrast‐associated cholangiocarcinoma. An epidemiologic and clinicopathologic study , 1982, Cancer.

[9]  K. Lindor,et al.  Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.

[10]  P. Jongsuksuntigul,et al.  Opisthorchiasis control in Thailand. , 2003, Acta tropica.

[11]  H. Sriplung,et al.  Cancer in Thailand. Vol. II 1992-1994. , 1999 .

[12]  B. Graubard,et al.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  J. Olsen,et al.  Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark , 1998, Hepatology.

[14]  E. Kouroumalis,et al.  Increasing incidence of cholangiocarcinoma in Crete 1992-2000. , 2002, Anticancer research.

[15]  S. Kubo,et al.  Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma , 2004, Cancer Science.

[16]  Hai-rim Shin,et al.  Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. , 1996, International journal of epidemiology.

[17]  K. McGlynn,et al.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? , 2004, Journal of hepatology.

[18]  O. Farges,et al.  Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries. , 2002, European journal of gastroenterology & hepatology.

[19]  K. Chayama,et al.  Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis , 2000, Cancer.

[20]  S. Hanai,et al.  Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand , 2005, International journal of cancer.

[21]  F. Callea,et al.  Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy , 2001, Cancer Causes & Control.

[22]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[23]  Jinbo Chen,et al.  Biliary tract cancer and stones in relation to chronic liver conditions: A population‐based study in Shanghai, China , 2007, International journal of cancer.

[24]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[25]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[26]  H. Adami,et al.  Excess risk of primary liver cancer in patients with diabetes mellitus. , 1996, Journal of the National Cancer Institute.

[27]  D. Parkin,et al.  Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma , 1991, International journal of cancer.

[28]  M Linet,et al.  Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. , 1997, Journal of the National Cancer Institute.

[29]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[30]  N A Koshurnikova,et al.  Liver Cancers in Mayak Workers , 2000, Radiation research.

[31]  R. Chapman.  Risk factors for biliary tract carcinogenesis. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  Chun-Ying Wu,et al.  What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? , 2002, Journal of gastroenterology and hepatology.

[33]  J. Cologne,et al.  Temporal changes in liver cancer incidence rates in Japan: Accounting for death certificate inaccuracies and improving diagnostic techniques , 2001, International journal of cancer.

[34]  D. Parkin,et al.  Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  Jiamei Yang,et al.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. , 2008, World journal of gastroenterology.

[36]  H. Bartsch,et al.  opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in thailand , 1991, International journal of cancer.

[37]  C. Wild,et al.  Liver cancer in Thailand. II. A case‐control study of hepatocellular carcinoma , 1991, International journal of cancer.

[38]  H. Thomas,et al.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998 , 2001, Gut.

[39]  B. Sripa,et al.  Relationship between parasite‐specific antibody responses and intensity of Opisthorchis viverrini infection in hamsters , 2000, Parasite immunology.